These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23399581)

  • 21. Excellent renal allograft survival in donor-specific antibody transplant patients--role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Dhanda R; Shah Y; Bardapure M; Bhattacharjya S; Sharma AK
    Transplantation; 2009 Aug; 88(3):444. PubMed ID: 19667954
    [No Abstract]   [Full Text] [Related]  

  • 22. Desensitization in the Setting of HLA-Incompatible Kidney Transplant.
    Malvezzi P; Jouve T; Noble J; Rostaing L
    Exp Clin Transplant; 2018 Aug; 16(4):367-375. PubMed ID: 29863455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.
    Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC
    Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathogenesis of acute allograft dysfunction in desensitized renal transplant recipients.
    Singh N; Sun Q; Nadasdy T; Adams P; Dipaola NR; Pesavento T; Winters H; Satoskar A; Yu Z; Henry M; Hadley GA; Pelletier RP
    Clin Transplant; 2012; 26(4):E402-11. PubMed ID: 22882695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-HLA antibody detection and rejection in kidney transplantation: impact of the new technologies].
    Georgescu D; Ferrari-Lacraz S; Villard J
    Rev Med Suisse; 2007 Apr; 3(108):1064-9. PubMed ID: 17552259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
    Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
    Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy.
    Martin L; Guignier F; Mousson C; Rageot D; Justrabo E; Rifle G
    Transplantation; 2003 Jul; 76(2):395-400. PubMed ID: 12883199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitization after kidney transplantation.
    Akalin E; Pascual M
    Clin J Am Soc Nephrol; 2006 May; 1(3):433-40. PubMed ID: 17699242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of pretransplant donor-specific antibodies on kidney allograft recipients with negative flow cytometry cross-matches.
    Kwon H; Kim YH; Choi JY; Shin S; Jung JH; Park SK; Han DJ
    Clin Transplant; 2018 Jun; 32(6):e13266. PubMed ID: 29676812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical importance of choosing the right assay for detection of HLA-specific donor-reactive antibodies.
    Sumitran-Karuppan S
    Transplantation; 1999 Aug; 68(4):502-9. PubMed ID: 10480407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid-phase HLA antibody detection methods and risk of renal allograft rejection in children.
    Book BK; Agrawal P; Dalla Vecchia LK; Gebel HM; Pescovitz MD; Tambur AR
    Transplant Proc; 2001; 33(1-2):403-4. PubMed ID: 11266883
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of pretransplant class I and II non-donor-specific anti-HLA immunization on immunologic outcome and graft survival in kidney transplant recipients.
    Staeck A; Khadzhynov D; Kleinsteuber A; Lehner L; Duerr M; Budde K; Lachmann N; Halleck F; Staeck O
    Transpl Immunol; 2020 Dec; 63():101333. PubMed ID: 32919027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unravelling the connections between donor specific antibodies and renal allograft pathology.
    Chapman JR; Wavamunno M; O'Connell PJ; Nankivell BJ
    Clin Transpl; 2013; ():361-5. PubMed ID: 25095530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The alloimmunized patient: monitoring and therapeutics.
    Braun WE
    Am J Med Sci; 1997 May; 313(5):279-82. PubMed ID: 9145037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study.
    Norin AJ; Mondragon-Escorpizo MO; Brar A; Hochman D; Sumrani N; Distant DA; Salifu MO
    Hum Immunol; 2013 Oct; 74(10):1304-12. PubMed ID: 23811689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection.
    Gill JS; Landsberg D; Johnston O; Shapiro RJ; Magil AB; Wu V; Tinckam K; Keown P
    Transplantation; 2010 Jan; 89(2):178-84. PubMed ID: 20098280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-Year Outcomes of Living Related Kidney Transplant in Patients With Preformed HLA Donor-Specific Antibodies: A Single-Center Experience in Malaysia.
    Jalalonmuhali M; Ng KP; Mohd Shariff NH; Lee YW; Wong AH; Gan CC; Lim SK
    Transplant Proc; 2020; 52(6):1718-1722. PubMed ID: 32448671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitization to HLA antigens occurs in 95% of primary renal transplant rejections.
    Harmer AW; Koffman CG; Heads AJ; Vaughan RW
    Transplant Proc; 1995 Feb; 27(1):666-7. PubMed ID: 7879137
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.